This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Isis Innovation Limited. Active years: 2013-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2018
Title: Emma Link: Innovator in Diagnostic Methods
Introduction
Emma Link is a prominent inventor based in Oxford, GB. She has made significant contributions to the field of diagnostic methods, particularly in understanding statin-induced myopathy. With a total of 2 patents to her name, Emma is recognized for her innovative approaches to medical diagnostics.
Latest Patents
Emma's latest patents focus on a method for determining an individual's susceptibility to statin-induced myopathy. This invention involves detecting the presence or absence of one or more polymorphisms in the SLCO1B1 gene from a biological sample. The presence of these polymorphisms indicates that the individual has an altered susceptibility to statin-induced myopathy, which can be crucial for personalized medicine.
Career Highlights
Emma Link is associated with Isis Innovation Limited, where she continues to develop her groundbreaking work in diagnostics. Her research has the potential to significantly impact patient care by providing tailored treatment options based on genetic predispositions.
Collaborations
Emma has collaborated with notable colleagues, including Sarah Parish and Rory Collins. These partnerships enhance her research and contribute to the advancement of medical diagnostics.
Conclusion
Emma Link is a trailblazer in the field of diagnostic methods, with her innovative patents paving the way for improved patient outcomes. Her work exemplifies the importance of genetic research in modern medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile